INTRODUCTION
The ovarian follicle is the basic unit of the ovary responsible for female reproduction and endocrine function. An ovarian follicle is composed of an oocyte, one or more layers of surrounding granulosa cells, and the outermost layer(s) of theca cells. Ovarian follicles change dynamically during development in terms of morphology, biological markers, and gene expression profiles. Once formed, most of the initial primordial follicles remain quiescent, and select numbers are reactivated over time and develop into primary, secondary, small antral, and antral follicles. Following ovulation, the remnants of the ruptured antral follicle form the corpus luteum. The follicle development process is accompanied by important cellular events including granulosa cell proliferation, apoptosis and differentiation, oocyte growth and maturation, and theca cell recruitment and differentiation. Factors involved in the regulation of this process include Kit ligand, FGF, GDF9, BMP-15, gonadotropins, and activin [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , although the mechanisms are not well understood.
Using microarray studies of activin-treated primary granulosa cells, we identified a gene network centering on retinoic acid (RA) as a target of activin action, and Cyp26b1, a gene that encodes a key RA-degrading enzyme, as the gene that was most significantly suppressed by activin [18] , suggesting the important role of RA in ovary development.
RA is an active derivative of vitamin A and a potent morphogen that regulates tissue organization, patterning, and growth. Dietary vitamin A is carried in blood by the retinolbinding protein (RBP) and transported into the cell through the binding of RBP to the receptor stimulated by retinoic acid 6 (STRA6) [19, 20] . Vitamin A then undergoes a series of enzymatic conversions to form RA. Cellular RA is either degraded by the P450 cytochrome enzymes CYP26A1, B1, and C1 or binds to RA receptors (RARs) for signaling. After binding to RA, RARs heterodimerize with retinoid X receptors (RXRs). RAR and RXR heterodimers then bind to retinoic acid response elements (RARE) and regulate the transcription of RA target genes [21] . RARs and RXRs each have three subtypes, a, b, and c, and each subtype has several isoforms [21, 22] .
In the embryonic ovary, RA and vitamin A have been shown to be important for controlling germ cell entry into meiosis [23, 24] . Our previous studies have shown that both activin and RA are able to stimulate the growth of primary cultured mouse granulosa cells. Cotreatment of RA or activin with the pan RAR inhibitor AGN194310 abolished the proliferative effect of RA or activin, suggesting the involvement of RAR-mediated signaling [18] . The mechanism(s) underlying RA stimulation of primary granulosa cell growth remains unknown.
Intracellular calcium (Ca 2þ ) signals also regulate a variety of cellular functions, including proliferation and apoptosis [25] .
Hormones, growth factors, and cytokines generate a Ca 2þ signal by stimulating the production of the second messenger inositol 1,4,5-trisphosphate (IP 3 ), which binds to the IP 3 signaling has been described in a number of cell types of the ovary [27] [28] [29] [30] , and plays a role in steroidogenesis [31] as well as luteinizing hormone and follicle-stimulating hormone signaling in the ovary [32] [33] [34] . It is possible that IP 3 Rdependent Ca 2þ signaling may be involved in RA action in the ovary as well.
Based on our previous findings and studies by others, the purpose of this study was to investigate whether RA induction of primary granulosa cell proliferation was mediated by modulation of Ca 2þ homeostasis and the functional significance of Ca 2þ signaling in RA actions. We have found that RA increases store-operated Ca 2þ entry, a plasma membrane Ca 2þ influx pathway, whose upregulation increases the [Ca 2þ ] in the ER store and therefore IP 3 R-dependent Ca 2þ release. Importantly, remodeling of the Ca 2þ signal by RA is required for RA-dependent RARE activation and increased proliferation in primary granulosa cells. RA regulation of Ca 2þ signaling is an essential feature of ovarian follicle development.
MATERIALS AND METHODS

Animals
CD-1 mice (Harlan Laboratories) were maintained on a 12L:12D cycle (lights off at 1800 h) with food and water available ad libitum. Animals were cared for in accordance with all federal and institutional guidelines, and all animal care and use protocols were approved by the DePaul IACUC.
Primary Granulosa Cell Collection, Culture, and Treatment
Granulosa cells for each experiment were collected and pooled from 12 to 16 ovaries from 22-to 23-day-old mice through follicle puncture and cultured as we described previously [18, 35, 36] . Oocytes were filtered out using a 40-lm cell strainer (BD Falcon). Granulosa cells were cultured in a humidified incubator at 378C and 5% CO 2 in Dulbecco modified Eagle medium/F-12 medium (Mediatech) supplemented with 2 lg/ml insulin, 5 lg/ml transferrin, 0.04 lg/ml hydrocortisone, and 10% fetal bovine serum (Mediatech). After they attached to the bottom of culture plates (;24 h), cells were given the following treatments every 24 h for 3 days: RA, 0.07 or 0.7 lM (atRA; SigmaAldrich); 2-aminoethoxydiphenylborane (2-APB), a blocker of IP 3 R-dependent ER Ca 2þ release and store-operated calcium entry (SOCE); 3 or 30 lM (SigmaAldrich); Xestospongin C, a selective IP 3 R antagonist that specifically blocks IP 3 R-dependent ER Ca 2þ release; 1 or 3 lM (Abcam); 3,5-bis (trifluoromethyl)pyrazole (BTP-2), the specific SOCE blocker, 1 or 10 lM (SigmaAldrich); or a combination of RA with 2-APB, Xestospongin C, or BTP-2. All treatments were given in fresh cell culture medium with the final concentration of vehicle (dimethyl sulfoxide [DMSO]) less than 0.05%. The doses of treatments were based on previous studies [18, 32] . Immediately following the treatments, Ca 2þ concentration measurements or cell proliferation assays were carried out as detailed below. ] cyto measurement using microscopy, cells cultured and treated on glass coverslips were loaded with either fluo-2 AM (10 lM) or fura-2 AM (2 lM) indicator for 60 min at room temperature and subjected to confocal or widefield fluorescence imaging, respectively. For confocal imaging, coverslips were mounted in a recording chamber positioned on the stage of an inverted microscope (IX71; Olympus America). Cells were visualized using a plan apo 603, 1.42 NA oil immersion objective, and confocal images were acquired using a VT-Infinity 3 laser (VisiTech International). Fluo-2 was excited using the 488 line of a krypton-argon laser. The emitted fluorescence was filtered using a bandpass filter set (VisiTech International) and collected and analyzed using HCImage software (Hamamatsu Corp.). The fluo-2 signal originating from cytoplasmic regions was normalized to that of the initial fluorescence value F 0 and expressed as F/F 0 . The chamber was continuously perfused with HBSS at room temperature, and a rapid solution changer was used to switch the composition of the solution bathing the cells under study. For widefield imaging, coverslips were mounted in a recording chamber positioned on the stage of an inverted fluorescence microscope (IX71; Olympus America). Fura-2 was alternately excited at 340 and 380 nm, and the emitted fluorescence was filtered at 510 nm, collected, and recorded using a charge-coupled device imaging system, using SimplePCI software (Hamamatsu Corp.). [Ca 2þ ] cyto is reported to be the ratio of background corrected fluorescence intensity at 340 nm and 380 nm. The chamber was continuously perfused with HBSS, and a solution changer was used to switch the composition of the solution bathing the cells as described above. 4 , 10 mM HEPES, and 1 mM EGTA, pH 7.4, with NaOH. Multiple image fields were acquired from each coverslip, and the data were pooled from at least 3 independent sets of coverslips acquired on at least 4 different days from independent cultures.
Cytoplasmic Calcium Concentration Measurement
Primary Granulosa Cell Transfection and Validation
Primary granulosa cells were collected and cultured in a 10-cm plate for 2 days before being lifted, counted, and transiently transfected with a Cyp26b1 overexpression construct (kindly provided by Dr. Krzysztof Palczewski, Case Western Reserve University) [37] , small interfering (siRNA) targeting Cyp26b1 (Dharmacon), or a pGL3-RARE-luciferase promoter reporter construct (Addgene) [38] . For controls, cells were transfected with the empty vector pcDNA3, the negative control siRNA (Dharmacon), or the pGL3-luciferase reporter vector. For all transfection, either 2 lg of DNA or 100 nM siRNA was applied per 1 3 10 6 cells. All transfection was performed using a Nucleofection system (Lonza Group, Ltd.) with the cells suspended in a transfection solution that came with the basic epithelial cell Nucleofector kit (Lonza Group Ltd.) following the manufacturer's instructions. Immediately after transfection, cells were plated into 12-, 24-, or 96-well plates to allow attachment to the bottom of each well before further assays. Cell attachment was observed within 24 h after plating. Western blot verification of CYP26B1 protein overexpression, realtime reverse-transcriptase (RT)-PCR validation of Cyp26b1 gene knockdown, or cell proliferation assays were performed at 72 h post transfection as described previously [18] . For the pGL3-RARE-luciferase reporter activity study, at 24 h post transfection, cells were treated for 24 h with RA at different concentrations in the presence or absence of 10 lM BTP-2, a specific SOCE blocker, or 30 lM 2-APB.
Western Blotting
Protein homogenates were collected from primary cultured granulosa cells of 22-to 23-day-old immature mice. Protein homogenates were prepared in cell lysis reagent (CelLytic MT; Sigma-Aldrich) or radioimmunoprecipitation assay lysis buffer (for samples probed for ORAI1; ThermoFisher). Proteins were electrophoresed and transferred to nitrocellulose or polyvinylidene fluoride (used for ORAI1 only) membranes. Blots were incubated with primary antibody overnight at 48C. Primary antibodies used in this study included goat anti-CYP26B1 antibody (1:1000 dilution; Everest Biotech), rabbit anti-STIM1 antibody (1:1000; Sigma-Aldrich), rabbit anti-ORAI1 antibody (1:250 dilution; Sigma-Aldrich), and rabbit anti-actin antibody (1:1000 dilution; SigmaAldrich). Blots were then incubated for 1 h at room temperature with horseradish peroxidase (HRP)-labeled secondary antibody (HRP anti-goat antibody; 1:8000 dilution [Zymed Laboratories]; or HRP anti-rabbit antibody, 1:5000 dilution [Promega]). Proteins were visualized by chemiluminescence.
RNA Isolation and Real-Time RT-PCR
Total RNA was isolated either from cultured and treated primary granulosa cells, using an RNeasy mini-kit (Qiagen). RNA was subjected to on-column deoxyribonuclease digestion and analyzed for quality using a bioanalyzer. The DEMCZUK ET AL.
resulting RNA was reverse transcribed with avian myeloblastosis virus-reverse transcriptase (Fisher Scientific). Real-time PCR was then performed using a real-time PCR system with SYBR Green PCR Master Mix (product 7300; Applied Biosystems) [39] . Primers were designed according to the complete mouse cDNA sequences of interest genes. A list of the primers used is shown in Table 1 . Ribosomal protein L19 was used as an internal control for all measurements, as we described previously [35] . Specificity of all real-time PCR reactions was also confirmed by a single peak in the melt curves and a single band of the predicted size after agarose gel electrophoresis of the PCR products (data not shown).
Cell Proliferation Assay
Primary granulosa cells were plated at 4 3 10 4 cells/well or 6 3 10 4 cells/ well in 96-well plates. After transfection or treatments as described above, cell proliferation assays were performed using a cell proliferation assay system (CellTiter96 AQueous One Solution; Promega) following the manufacturer's instructions [18] . Absorbance at 490 nm was obtained using a 96-well plate reader. In addition to cells that were used as control or treatment groups, serially diluted cells with known cell numbers were also plated in duplicates in each plate to serve as standards for the plate. Cell numbers were calculated according to readings from standards plated in the same plates [18] .
Luciferase Assays
Primary granulosa cells transfected with either the pGL3-luciferase reporter vector control construct or the pGL3-RARE-luciferase promoter reporter construct were washed with ice-cold phosphate-buffered saline and lysed on ice for 20 min at the end of treatments. A luciferase assay systems kit (Promega) was then used to measure luciferase activity following the manufacturer's instructions. Reagents were added using an automatic injector, and emitted luminescence was measured using a GloMax 96 microplate luminometer (Promega) for 10 s. Relative light units were normalized for total protein content measured with a protein assay reagent (Bio-Rad) as described previously [35] .
Data Analysis and Statistics
Data are mean 6 SEM. For statistical comparisons between two groups, Student two-tailed t test was used. For statistical comparisons among multiple groups, one-way analysis of variance followed by the Tukey-Kramer post hoc analysis was used. A P value of , 0.05 was considered significant.
RESULTS
RA Promotes IP 3 R-Dependent Ca 2þ Release
To determine whether RA treatment affected IP 3 R-dependent Ca 2þ signaling, [Ca 2þ ]cyto was measured in mouse granulosa cells treated with RA or vehicle control. Previous studies have demonstrated that ATP application generates an IP 3 R-dependent intracellular Ca 2þ signal in either mouse luteinized granulosa cells [29] or human granulosa-luteal cells [27, 28] by binding to G protein-coupled purinergic P2Y receptors. A fluorescence plate reader was used to monitor [Ca 2þ ] cyto , using fluo-2 as the Ca 2þ indicator. To confirm that RA treatment itself had no effect on fluo-2 loading, we measured average fluorescence in wells containing fluo-2-loaded control and RA-treated cells prior to stimulation. There were no differences (Student t-test) in the fluorescence signal (mean 6 SEM) pooled from 64 control (19.2 6 0.2 fluorescence units) and 64 RA-treated (19.4 6 0.2 fluorescence units) wells of three independent plates containing cells from three animals, demonstrating that RA treatment per se did not affect fluo-2 signal. Using this approach, we examined the response in a population of cells challenged with increasing concentrations of ATP (Fig. 1A) . While these data tell us that the RA-treated group responded more robustly to ATP stimulation (Fig. 1B) , we cannot say whether this was due to an increased response of individual cells or an increase in the number of responding cells. Single-cell experiments were therefore carried out to further define the effect of RA treatment. ATP-generated Ca 2þ signals in granulosa cells are mediated by IP 3 R-dependent ER Ca 2þ release. To rule out the possibility of Ca 2þ influx across the plasma membrane, ATP (saturating dose) was applied in EGTA-buffered Ca 2þ -free medium and Ca 2þ transients recorded in single granulosa cells (Fig. 1, C, D , and E). To maintain consistency with plate reader experiments, fluo-2 was used as Ca 2þ indicator. As with the plate reader experiment, Ca 2þ transient amplitudes were increased in the RA-treated group (Fig. 1, D [40] . The ratiometric indicator fura-2 was used measure [Ca 2þ ] cyto in these experiments. The use of a ratiometric indicator corrects for potential artifacts due to variability in dye loading. The ratio of fluorescence intensities at 340 and 380 nm is directly related to [Ca 2þ ]cyto and can be compared between cells. Using this approach to monitor [Ca 2þ ] ER in single granulosa cells revealed the steady-state [Ca 2þ ] ER content to be significantly larger in RA than in treated control cells (Fig. 2, A and B) . These data are consistent with the hypothesis that RA treatment increases IP 3 R-dependent Ca 2þ release by increasing [Ca 2þ ] ER . Store depletion activates a plasma membrane Ca 2þ influx pathway known as SOCE [40] . The degree of activation of this pathway becomes apparent when Ca 2þ is restored to the extracellular medium in the maintained presence of CPA ( Fig.  2A) . Interestingly, the magnitude of SOCE is larger in cells treated with RA than in vehicle control (Fig. 2, A and C) . The function of SOCE is to replenish the ER Ca 2þ store, so an increase in SOCE provides a possible explanation for the increased [Ca 2þ ] ER content and IP 3 R-dependent Ca 2þ release in the RA treated cells. 
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RA Increases STIM1 and ORAI1 Expression Levels
SOCE is mediated by the Ca 2þ release-activated Ca 2þ (CRAC) channels, activated in response to depletion of endoplasmic reticulum (ER) Ca 2þ stores. The molecular machinery consists of the ER-localized stromal interaction molecule (STIM), which, upon store depletion, binds to and opens ORAI1, the plasma membrane pore-forming subunit of the CRAC channel [41] . Increased expression levels of STIM and ORAI have been widely associated with increased SOCE and ER Ca 2þ store content [41] . There are 2 STIM and 3 ORAI isoforms. We therefore assessed the effect of RA treatment on the expression levels of STIM and ORAI isoforms. Early increases (24 h) in levels of Orai1 and Stim1 mRNA expression were seen in response to 0.07 lM RA (Fig. 3A) . Because ORAI1 and STIM1 are the dominant isoforms, and increases in their expression are known to increase SOCE, we assayed protein levels after 72 h RA (0.07 lM) to reproduce the conditions in which increased SOCE was observed (Fig. 2) . Consistent with the mRNA data, a robust increase in Orai1 and STIM1 protein was observed with RA treatment (Fig. 3B ) (for full-length blots, see Supplemental Fig. S1 ; all supplemental data are available online at www.biolreprod.org).
Stimulatory Effect of RA on Proliferation of Primary Granulosa Cells Is Ca 2þ -Dependent
We reported previously that RA or a CYP26 inhibitor stimulated the growth of primary cultured granulosa cells [18] . As a key RA-degrading enzyme, changes in CYP26B1 levels or action can alter RA levels and result in significant biological consequences [18, [42] [43] [44] . To further investigate the regulation of granulosa functions by CYP26B1 and RA, we first examined the effect of Cyp26b1 overexpression and knockdown on granulosa cell numbers. Overexpression of Cyp26b1 increased CYP26B1 protein levels (Fig. 4A, Supplemental Fig.  S1 ) and resulted in a decrease in granulosa cell numbers ( RETINOIC ACID REGULATES CALCIUM SIGNALING 4B). Knocking down the expression of Cyp26b1 by using a siRNA cocktail decreased the mRNA levels of Cyp26b1 (Fig.  4C ) and resulted in an increase in granulosa cell proliferation (Fig. 4D) . These results further demonstrate that modulation of RA levels through Cyp26b1 overexpression or knockdown has a profound effect on granulosa cell growth status.
To determine whether the proliferative effect of RA on granulosa cell proliferation is mediated by Ca 2þ signaling, we treated primary granulosa cells with RA in the presence or absence of 2-APB, a blocker of IP 3 R-dependent ER Ca 2þ release and SOCE. As expected, RA induced granulosa cell proliferation, whereas cotreatment of RA with 3 lM or 30 lM (Fig. 5) 2-APB dose-dependently abolished the stimulatory effect of RA. Treatments with 2-APB alone also dosedependently suppressed basal level granulosa cell growth (Fig. 5) , suggesting that Ca 2þ mediates endogenous RA signaling as well. At either dose, 2-APB did not affect cell survival (Supplemental Fig. S2 ) or morphology. The amount of vehicle (DMSO) presented in the control or experimental groups had no effect on cell proliferation (Supplemental Fig.  S3 ). These results demonstrate that RA regulation of granulosa cell proliferation is indeed dependent on [Ca 2þ ]cyto. Because 2-APB blocks both the IP 3 R-dependent ER Ca 2þ release and the SOCE, to further investigate the role of IP 3 Rdependent Ca 2þ signaling, we treated cells with a specific blocker of IP 3 R-dependent ER Ca 2þ release, Xestospongin C, and also with a specific blocker of SOCE, BTP-2. The results showed that RA induced granulosa cell proliferation while cotreatment of RA with 1 lM or 3 lM Xestospongin C abolished this effect (Fig. 6) . Treatments with Xestospongin C alone at 3 lM also suppressed basal level granulosa cell growth (Fig. 6) , again suggesting the involvement of Ca 2þ pathway in endogenous RA signaling. Treatment with 1 lM or 10 lM BTP-2 also inhibited or abolished the proliferative effect of RA (Fig. 7) . At either dose, Xestospongin C or BTP-2 did not affect cell survival (Supplemental Fig. S2 ) or morphology. These results therefore demonstrate that the proliferative effect of RA is at least partially mediated through Ca 2þ signaling.
RA Activation of RARE Is Ca 2þ -Dependent
Because RA functions through its binding to RARs, which heterodimerize with RXRs and bind to RARE to regulate gene transcription, to further investigate the functional significance and molecular mechanisms of Ca 2þ signaling in RA action, we examined RARE activation by RA in the presence or absence of Ca 2þ signaling blockers in primary granulosa cells transfected with a pGL3-RARE-luciferase reporter construct. When granulosa cells were transfected with a control pGL3-luciferase construct, no luciferase activity was observed with or without RA treatments (Fig. 8A) . When granulosa cells were FIG. 5. Treatment with 2-APB abolishes RA stimulation of granulosa cell proliferation. RA stimulated while 2-APB inhibited the proliferation of primary cultured granulosa cells, and the stimulatory effect of RA was abolished by 2-APB at 3 and 30 lM. Primary cultured granulosa cells were plated at 6 3 10 4 cells/well and treated for 3 days prior to cell proliferation assay. Different letters indicate statistically significant differences, according to ANOVA followed by the Tukey test. P , 0.05; n ¼ 4.
FIG. 6. Treatment with Xestospongin C abolishes RA stimulation of granulosa cell proliferation. RA stimulated while Xestospongin C inhibited the proliferation of primary cultured mouse granulosa cells, and the stimulatory effect of RA was abolished by Xestospongin C at 1 and 3 lM. Primary cultured granulosa cells were plated at 6 3 10 4 cells/well and treated for 3 days prior to cell proliferation assay. Different letters indicate statistically significant differences, according to ANOVA followed by the Tukey test. P , 0.05; n ¼ 4.
FIG. 7.
Treatment with BTP-2 abolishes RA stimulation of granulosa cell proliferation. RA stimulated while BTP-2 inhibited the proliferation of primary cultured mouse granulosa cells, and the stimulatory effect of RA was suppressed by BTP-2 at 1 lM and abolished at 10 lM. Primary cultured granulosa cells were plated at 4 3 10 4 cells/well and treated for 3 days prior to cell proliferation assay. Different letters indicate statistically significant differences, according to ANOVA followed by the Tukey test. P , 0.05; n ¼ 3.
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transfected with the pGL3-RARE-luciferase reporter construct, basal levels of luciferase activity were observed, suggesting the presence of endogenous RA; and exogenous RA treatments were able to further induce luciferase activity, suggesting RARE activation by the treatments (Fig. 8B) . To investigate the role of Ca 2þ signaling in RAR mediated RA signaling and therefore RARE activation, transfected cells were treated with RA in the presence or absence of two Ca 2þ signaling blockers, 2-APB, which blocks IP 3 R-mediated signaling, and SOCE, and BTP-2, which specifically blocks SOCE. As expected, RA induced RARE activation dose-dependently (Fig. 8B , open bars), while such activation was reduced when RA was given together with either of the two Ca 2þ signaling blockers (Fig.  8B, gray and solid bars) . These results suggest that RA signaling through RARs and RARE is mediated at least in part by Ca 2þ signaling.
DISCUSSION
Both RA and Ca 2þ signaling pathways are involved in cell proliferation. This study demonstrated that, in the mouse ovary, RA stimulates granulosa cell proliferation and that this stimulatory effect is at least in part mediated through regulating Ca 2þ signaling pathway. This study also demonstrated that Ca 2þ signaling is involved in RA action through RARE activation. The crosstalk between these two signaling pathways may play a role in regulating ovarian follicle development.
RA has been known to play a critical role in embryo development. Knockout of retinaldehyde dehydrogenase 2 (RADLH2), a key RA synthesis enzyme, leads to defects in early embryonic formation of optic cup and forebrain [45, 46] . A microarray study comparing gene expression profiles in wild-type versus RADLH2 null (Raldh2
) mouse embryos has shown that in the absence of RA action, a number of important cellular functions are significantly affected, and Ca 2þ signaling is one of them [47] . When treated with RA, increased gene expression of Ca 2þ signaling-related components has been observed in NB4 cells, an acute promyelocytic leukemia cell line, suggesting activation of Ca 2þ -mediated pathway(s) [48] . Our findings show that RA treatment increases the amount of Ca 2þ in the ER. This effect is most likely mediated through RA induction of channel proteins critical for SOCE, such as the ORAI and STIM proteins. We also demonstrate that this translates into increased IP 3 R-dependent Ca 2þ signaling. In addition to IP 3 Rs, granulosa cells also express ryanodine receptor (RyR) Ca 2þ release channels on the ER [29] . Importantly, these channels are gated by Ca 2þ itself and, through crosstalk with IP 3 R, can function to amplify ERgenerated Ca 2þ signals [25, 29] . The consequences of RAinduced changes in ER Ca 2þ on IP 3 R-RyR crosstalk remain to be explored.
We show that increasing endogenous RA levels through silencing the Cyp26b1 gene or administering exogenous RA can all stimulate the proliferation of primary granulosa cells. On the other hand, overexpressing CYP26B1 reduces granulosa cell numbers, which may be a result of decreased posttransfection proliferation or increased posttransfection cell death because certain levels of cell death are expected following the transfection procedure. The cells show no signs of differentiation or morphological changes over time in culture, although, as expected, changes in the cell numbers were obviously visible even under microscope. RA regulation of cell fate is complicated and cell-type specific. In some cancerous cells, for example, neuroblastoma cells, acute promyelocytic leukemia cells, and mammary carcinoma cells, RA induces differentiation, enhances apoptosis, and/or inhibits proliferation [49, 50] . In some normal growing cells, for example, embryonic neurons, immature neurons during adult neurogenesis, skin epithelial cells, and primary granulosa cells, as shown in our studies, RA either prevents differentiation, promotes cell survival, or induces proliferation [18, 50] . Even in the same cell type (e.g., aortic smooth muscle cells), RA may either stimulate or inhibit cell proliferation, depending on the absence or presence of other growth factors, respectively [51] . RA effect on tumor growth is stage sensitive as it may show no Effect of indicated treatments on RARE activation. RA induced RARE activation dose-dependently, whereas such activation was abolished when RA was given together with either of the two Ca 2þ signaling blockers, 2-APB or BTP-2. Primary granulosa cells were treated for 24 h with RA in the presence or absence of 10 lM BTP-2 or 30 lM 2-APB. Cell lysates were then subjected to luciferase activity assay. Different letters indicate statistically significant differences, according to ANOVA followed by the Tukey test. P , 0.05; n ¼ 4.
RETINOIC ACID REGULATES CALCIUM SIGNALING or even a stimulatory effect if given together with carcinogen at the early stages of tumor formation, while an inhibitory effect is seen in the absence of a carcinogen at later stages of tumor formation [52] . The differential effects of RA depend on the content and balance of each signaling component and are subject to the regulation of other signaling pathways [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] . The transcription cofactors recruited by the RAR-RXR pathway can be cell-type specific [63] [64] [65] . In addition, in cells expressing high levels of the intracellular lipid binding protein FABP5, RA can signal through the nuclear receptors PPARb/d, instead of RARs, and therefore activate prosurvival pathways [50, 66] .
In the current study, we demonstrated that modulation of Ca 2þ signaling by RA is a requirement for the maximal stimulatory effect of RA on granulosa cell proliferation. Furthermore, Ca 2þ signaling is involved in RA activation of RARE. These results further confirm the functional significance of Ca 2þ signaling in mediating the intraovarian actions of RA. Future studies will further investigate the specificity of Ca 2þ signaling in RA-induced cell proliferation as well as its stage specificity. Interestingly, the differentiation and apoptosis induction effects of RA in neuroblastoma cells and acute promyelocytic leukemia cells are also mediated by Ca 2þ signaling, although in those cases, RA suppresses Ca 2þ signaling [67] . Suppression of Ca 2þ signaling through calmodulin-dependent protein kinase IV (CaMKIV) with a synthetic CaMK inhibitor alone can enhance terminal differentiation of leukemia cells [68] . Therefore, whether Ca 2þ signaling is induced or suppressed by RA may serve as a determining factor that leads to the cell fate of either proliferation or differentiation, depending on the activation or suppression of multiple downstream signaling pathways.
Our previous studies identified interplay between activin and RA signaling pathways in the ovary; that is, activin A suppresses the expression of Cyp26b1; the expression patterns of Cyp26b1 mRNA are inversely correlated with those of Inhba mRNA (encodes activin bA subunit) in follicles; and signaling through RARs partially mediates activin A induction of granulosa cell proliferation [18] . It has been reported that activin actions also require Ca 2þ signaling. Activin induces the proliferation of follicle-simulating hormone-secreting cells in the pituitary gland through Ca 2þ -dependent signaling [69] . In pancreatic beta-cells, activin A stimulates Ca 2þ influx and induces beta-cell function, while activin B inhibits Ca 2þ influx and inhibits beta-cell function, possibly due to ALK7-mediated activin B signaling [70] . It has been discovered that calmodulin directly binds to the activin signaling proteins, Smads, and may regulate Smad action in a Ca 2þ -dependent manner [71] . Ca 2þ in turn regulates activin expression as increased [Ca 2þ ] cyto and Ca 2þ signaling through calmodulin induce Inhba gene expression in mast cells [72] . These observations and the findings from our current study strongly suggest that activin and RA actions in the ovary may share a common signaling pathway(s). Synergistic effect of activin A and RA in increasing depolarization-induced Ca 2þ influx through L-type Ca 2þ channels has been observed in neuroblastoma cells [73] . It is plausible to speculate that Ca 2þ signaling may serve as a converging pathway for some critical intraovarian actions of activin and RA, although further investigations are required to examine this idea.
Overall, the findings from this study support a model in which RA regulates ovarian follicle development by stimulating granulosa cell proliferation and this stimulatory effect is at least in part driven by the modulation of Ca 2þ signals mediated by increased [Ca 2þ ] ER and IP 3 R-dependent Ca 2þ release from the ER. This important intersection between RA and calcium signaling provides a better understanding of RA action in the ovary. In addition, the findings provide strong evidence that further supports a role for RA as a regulator of ovary development.
